Currency in IDR
| Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 0 | 0 | 6 | 6 |
| Avg. Estimate | 0 | 0 | 242.1 | 225.96 |
| Low estimate | 0 | 0 | 209.82 | 161.4 |
| High estimate | 0 | 0 | 274.38 | 306.66 |
| Year ago EPS | N/A | N/A | 209.82 | 242.1 |
| Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 0 | 0 | 7 | 7 |
| Avg. Estimate | N/A | N/A | 35.25T | 34.39T |
| Low estimate | N/A | N/A | 32.75T | 29.68T |
| High estimate | N/A | N/A | 37.82T | 38.82T |
| Year ago sales | N/A | N/A | 36.3T | 35.25T |
| Sales growth (year/est) | N/A | N/A | -2.90% | -2.40% |
| Earnings history | Invalid Date | Invalid Date | Invalid Date | 31/12/2023 |
|---|
| Est. EPS | N/A | N/A | N/A | 16.14 |
| Actual EPS | N/A | N/A | N/A | 48.42 |
| Difference | N/A | N/A | N/A | 32.28 |
| Surprise % | N/A | N/A | N/A | 200.00% |
| EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0 | 0 | 242.1 | 225.96 |
| 7 days ago | 0 | 0 | 244.68 | 228.37 |
| 30 days ago | 0 | 0 | 237.04 | 221.24 |
| 60 days ago | 0 | 0 | 218.21 | 218.21 |
| 90 days ago | 0 | 0 | 234.83 | 219.18 |
| EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | MEDC.JK | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | 15.40% | N/A | N/A | N/A |
| Next year | -6.70% | N/A | N/A | N/A |
| Next 5 years (per annum) | -5.90% | N/A | N/A | N/A |
| Past 5 years (per annum) | 112.56% | N/A | N/A | N/A |
